ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,672,238 | -7.0% | 231,988 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,024,860 | -46.1% | 231,988 | -30.1% | 0.00% | -50.0% |
| Q2 2022 | $9,330,436 | +113.4% | 332,044 | +250.4% | 0.00% | +100.0% |
| Q1 2022 | $4,371,765 | -3.3% | 94,750 | +76.2% | 0.00% | 0.0% |
| Q4 2021 | $4,521,000 | +26.1% | 53,783 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,584,000 | +68.8% | 53,783 | +34.8% | 0.00% | – |
| Q2 2021 | $2,123,000 | +69.2% | 39,906 | +38.0% | 0.00% | – |
| Q1 2021 | $1,255,000 | +145.6% | 28,926 | +193.8% | 0.00% | – |
| Q4 2020 | $511,000 | – | 9,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |